APOE and Alzheimer disease: However, piecing together findings from preclinical work in AD-like Tg models, the finding of protective effects in APOE ε4 carriers and the overall results of the ADAPT trial, it seems likely that NSAIDs may exert a protective effect but only if administered early on in the disease course.